Clinical Trial

A Randomised Clinical Investigation to Assess Efficacy of Low Volume Transanal Irrigation by Qufora® IrriSedo MiniGo Versus Conservative Treatment for Low Anterior Resection Syndrome Patients

Study acronym: MINIGO
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this post-market clinical follow up study is to assess the efficacy on clinical symptoms of LARS of low volume Transanal Irrigation by MiniGo in conjunction with conservative treatment versus conservative treatment at 3 months.
Trial Details
NCT Number NCT06923150
Lead Sponsor Qufora A/S
Collaborators: EVAMED
Conditions Gastroenterology, LARS - Low Anterior Resection Syndrome, Rectal Cancer
Enrollment 78 participants
Start Date 2024-06-18
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-11